FDA rebuffs MEI, Kyowa Kirin as another cancer drug class draws scrutinyMarch 25, 2022US curtails use of Vir, GSK’s COVID-19 drug as omicron subvariant spreadsMarch 28, 2022 0 Published by at March 28, 2022 Categories Tags Accelerate your path to novel, reliable answers with expert-curated biomedical and clinical data.
